157 related articles for article (PubMed ID: 19850041)
1. Inhibition of aldose reductase by dietary antioxidant curcumin: mechanism of inhibition, specificity and significance.
Muthenna P; Suryanarayana P; Gunda SK; Petrash JM; Reddy GB
FEBS Lett; 2009 Nov; 583(22):3637-42. PubMed ID: 19850041
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of new arylsulfonylspiroimidazolidine-2',4'-diones and study of their effect on stimulation of insulin release from MIN6 cell line, inhibition of human aldose reductase, sorbitol accumulations in various tissues and oxidative stress.
Iqbal Z; Morahan G; Arooj M; Sobolev AN; Hameed S
Eur J Med Chem; 2019 Apr; 168():154-175. PubMed ID: 30818176
[TBL] [Abstract][Full Text] [Related]
3. Ponalrestat: a potent and specific inhibitor of aldose reductase.
Ward WH; Sennitt CM; Ross H; Dingle A; Timms D; Mirrlees DJ; Tuffin DP
Biochem Pharmacol; 1990 Jan; 39(2):337-46. PubMed ID: 2105733
[TBL] [Abstract][Full Text] [Related]
4. Structure based comprehensive modelling, spatial fingerprints mapping and ADME screening of curcumin analogues as novel ALR2 inhibitors.
Verma SK; Thareja S
PLoS One; 2017; 12(4):e0175318. PubMed ID: 28399135
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of aldose reductase by Gentiana lutea extracts.
Akileshwari C; Muthenna P; Nastasijević B; Joksić G; Petrash JM; Reddy GB
Exp Diabetes Res; 2012; 2012():147965. PubMed ID: 22844269
[TBL] [Abstract][Full Text] [Related]
6. Benzoxazinone-thiosemicarbazones as antidiabetic leads via aldose reductase inhibition: Synthesis, biological screening and molecular docking study.
Shehzad MT; Imran A; Njateng GSS; Hameed A; Islam M; Al-Rashida M; Uroos M; Asari A; Shafiq Z; Iqbal J
Bioorg Chem; 2019 Jun; 87():857-866. PubMed ID: 30551808
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of aldose reductase in human erythrocytes by vitamin C.
Vincent TE; Mendiratta S; May JM
Diabetes Res Clin Pract; 1999 Jan; 43(1):1-8. PubMed ID: 10199583
[TBL] [Abstract][Full Text] [Related]
8. All in the family: aldose reductase and closely related aldo-keto reductases.
Petrash JM
Cell Mol Life Sci; 2004 Apr; 61(7-8):737-49. PubMed ID: 15094999
[TBL] [Abstract][Full Text] [Related]
9. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications.
Saraswat M; Muthenna P; Suryanarayana P; Petrash JM; Reddy GB
Asia Pac J Clin Nutr; 2008; 17(4):558-65. PubMed ID: 19114390
[TBL] [Abstract][Full Text] [Related]
10. In vitro retinal and erythrocyte polyol pathway regulation by hormones and an aldose reductase inhibitor.
Hotta N; Kakuta H; Koh N; Fukasawa H; Yasuma T; Awaya S; Sakamoto N
Diabetes Res Clin Pract; 1991 Oct; 14(1):29-35. PubMed ID: 1748061
[TBL] [Abstract][Full Text] [Related]
11. Pyridothiadiazine derivatives as aldose reductase inhibitors having antioxidant activity.
Zhu S; Zhang S; Hao X; Qin X; Parveen S; Yang S; Ma B; Zhu C
J Enzyme Inhib Med Chem; 2016; 31(sup1):126-130. PubMed ID: 27153454
[TBL] [Abstract][Full Text] [Related]
12. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members.
O'connor T; Ireland LS; Harrison DJ; Hayes JD
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):487-504. PubMed ID: 10510318
[TBL] [Abstract][Full Text] [Related]
13. Rat kidney aldose reductase and aldehyde reductase and polyol production in rat kidney.
Sato S
Am J Physiol; 1992 Nov; 263(5 Pt 2):F799-805. PubMed ID: 1443170
[TBL] [Abstract][Full Text] [Related]
14. Dihydrobenzoxazinone derivatives as aldose reductase inhibitors with antioxidant activity.
Chen H; Zhang X; Zhang X; Fan Z; Liu W; Lei Y; Zhu C; Ma B
Bioorg Med Chem; 2020 Oct; 28(20):115699. PubMed ID: 33069078
[TBL] [Abstract][Full Text] [Related]
15. Aldose and aldehyde reductase in animal tissues.
Flynn TG
Metabolism; 1986 Apr; 35(4 Suppl 1):105-8. PubMed ID: 3083200
[TBL] [Abstract][Full Text] [Related]
16. Kinetic characteristics of ZENECA ZD5522, a potent inhibitor of human and bovine lens aldose reductase.
Cook PN; Ward WH; Petrash JM; Mirrlees DJ; Sennitt CM; Carey F; Preston J; Brittain DR; Tuffin DP; Howe R
Biochem Pharmacol; 1995 Apr; 49(8):1043-9. PubMed ID: 7748183
[TBL] [Abstract][Full Text] [Related]
17. A highly specific aldose reductase inhibitor, ethyl 1-benzyl-3-hydroxy-2(5H)-oxopyrrole-4-carboxylate, and its congeners.
Mylari BL; Beyer TA; Siegel TW
J Med Chem; 1991 Mar; 34(3):1011-8. PubMed ID: 1900532
[TBL] [Abstract][Full Text] [Related]
18. Correlation of binding constants and molecular modelling of inhibitors in the active sites of aldose reductase and aldehyde reductase.
Carbone V; Zhao HT; Chung R; Endo S; Hara A; El-Kabbani O
Bioorg Med Chem; 2009 Feb; 17(3):1244-50. PubMed ID: 19121944
[TBL] [Abstract][Full Text] [Related]
19. (2,6-Dimethylphenylsulphonyl)nitromethane: a new structural type of aldose reductase inhibitor which follows biphasic kinetics and uses an allosteric binding site.
Ward WH; Cook PN; Mirrlees DJ; Brittain DR; Preston J; Carey F; Tuffin DP; Howe R
Biochem Pharmacol; 1991 Nov; 42(11):2115-23. PubMed ID: 1958230
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide prevents aldose reductase activation and sorbitol accumulation during diabetes.
Chandra D; Jackson EB; Ramana KV; Kelley R; Srivastava SK; Bhatnagar A
Diabetes; 2002 Oct; 51(10):3095-101. PubMed ID: 12351453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
